Jiangsu, China

Yifei Yang

This inventor holds 1 USPTO granted patent. Top assignees: China Pharmaceutical University, Chinese Academy of Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yifei Yang. Retrieved from https://idiyas.com/inventor/yifei-yang-9ov76xu5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yifei Yang: Innovator in Pharmaceutical Chemistry

Introduction

Yifei Yang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that activate the STING pathway, which is crucial for immune response.

Latest Patents

Yifei Yang holds a patent for "Substituted pyrazolecarboxamides as sting activators." This patent includes a heterocyclic amide compound of general formula (I), a pharmaceutically acceptable salt thereof, and a preparation method. The compound is utilized in the preparation of drugs for treating diseases related to STING activity, as well as in the formulation of immunologic adjuvants.

Career Highlights

Throughout his career, Yifei Yang has worked with esteemed institutions such as the Chinese Academy of Sciences and China Pharmaceutical University. His work has focused on innovative approaches to drug development and immune system modulation.

Collaborations

Yifei Yang has collaborated with notable colleagues, including Wenhu Duan and Meiyu Geng, contributing to advancements in their shared field of research.

Conclusion

Yifei Yang's innovative work in pharmaceutical chemistry and his patent on STING activators highlight his role as a key figure in advancing medical science. His contributions continue to influence the development of new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…